What does Docteur Christophe CHANTRAIN do?

Docteur Christophe CHANTRAIN is a specialist medical practice in Dalhem. Private Limited, started on 10 December 2013, 1 establishment.

What is the address of Docteur Christophe CHANTRAIN?

The registered office of Docteur Christophe CHANTRAIN is located at Chemin du Bois du Roi(WAR) 43, 4608 Dalhem.

Is Docteur Christophe CHANTRAIN still active?

Yes. According to the CBE (18 September 2026) Docteur Christophe CHANTRAIN is active, legal situation “Normale toestand”, started on 10 December 2013.

Is Docteur Christophe CHANTRAIN registered on Peppol?

Yes, Docteur Christophe CHANTRAIN is registered on the Peppol network with ID 0208:0542859114.

What is the enterprise number of Docteur Christophe CHANTRAIN?

The enterprise number of Docteur Christophe CHANTRAIN is BE0542859114.

When was Docteur Christophe CHANTRAIN founded?

Docteur Christophe CHANTRAIN was founded on 10 December 2013.

Who are the directors of Docteur Christophe CHANTRAIN?

According to the 2024 annual accounts, the directors of Docteur Christophe CHANTRAIN are: Nathalie MATHURIN, Christophe CHANTRAIN.

Is Docteur Christophe CHANTRAIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 December 2013; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did Docteur Christophe CHANTRAIN make in 2024?

Docteur Christophe CHANTRAIN posted a profit after taxes of € 28,843 in financial year 2024.

What is the revenue of Docteur Christophe CHANTRAIN?

As a small company, Docteur Christophe CHANTRAIN is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 74,959.

Docteur Christophe CHANTRAIN (Private Limited) - Dalhem

Dossier Docteur Christophe CHANTRAIN, printed on 18 September 2026 from databakkes.be/en/0542859114/docteur-christophe-chantrain. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Docteur Christophe CHANTRAIN from Dalhem, company number BE0542859114, closed financial year 2024 with a result of € 28,843 after tax. For that financial year Docteur Christophe CHANTRAIN recorded a gross margin of € 74,959 and equity of € 111,995. Compared with financial year 2023, the result moved from € 7,883 to € 28,843. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2025.

What it is worth Growing

€ 111,995

▲ 3% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 28,843

▲ 266% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 48,835

▼ 50% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 25,600 paid out

89 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 3,930

▼ 8% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,035

▲ 260% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,280

▼ 43% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 52,076 Gross margin 2021: € 52,076 First fiscal year in the series	€ 36,599 Gross margin 2022: € 36,599 ▼ 30% vs 2021 (€ 52,076) Unfavourable step	€ 74,316 Gross margin 2023: € 74,316 ▲ 103% vs 2022 (€ 36,599) Favourable step	€ 74,959 Gross margin 2024: € 74,959 ▲ 1% vs 2023 (€ 74,316) Favourable step	▲ 1%
Profit after taxes	€ 32,556 Profit after taxes 2021: € 32,556 First fiscal year in the series	€ 18,836 Profit after taxes 2022: € 18,836 ▼ 42% vs 2021 (€ 32,556) Unfavourable step	€ 7,883 Profit after taxes 2023: € 7,883 ▼ 58% vs 2022 (€ 18,836) Unfavourable step	€ 28,843 Profit after taxes 2024: € 28,843 ▲ 266% vs 2023 (€ 7,883) Favourable step	▲ 266%
Equity	€ 111,034 Equity 2021: € 111,034 First fiscal year in the series	€ 129,870 Equity 2022: € 129,870 ▲ 17% vs 2021 (€ 111,034) Favourable step	€ 108,753 Equity 2023: € 108,753 ▼ 16% vs 2022 (€ 129,870) Unfavourable step	€ 111,995 Equity 2024: € 111,995 ▲ 3% vs 2023 (€ 108,753) Favourable step	▲ 3%
Total debts	€ 19,489 Total debts 2021: € 19,489 First fiscal year in the series	€ 14,742 Total debts 2022: € 14,742 ▼ 24% vs 2021 (€ 19,489) Favourable step	€ 44,319 Total debts 2023: € 44,319 ▲ 201% vs 2022 (€ 14,742) Unfavourable step	€ 5,315 Total debts 2024: € 5,315 ▼ 88% vs 2023 (€ 44,319) Favourable step	▼ 88%
Cash	€ 89,029 Cash 2021: € 89,029 First fiscal year in the series	€ 110,827 Cash 2022: € 110,827 ▲ 24% vs 2021 (€ 89,029) Favourable step	€ 97,220 Cash 2023: € 97,220 ▼ 12% vs 2022 (€ 110,827) Unfavourable step	€ 48,835 Cash 2024: € 48,835 ▼ 50% vs 2023 (€ 97,220) Unfavourable step	▼ 50%
Retained profit	€ 92,434 Retained profit 2021: € 92,434 First fiscal year in the series	€ 111,270 Retained profit 2022: € 111,270 ▲ 20% vs 2021 (€ 92,434) Favourable step	€ 90,153 Retained profit 2023: € 90,153 ▼ 19% vs 2022 (€ 111,270) Unfavourable step	€ 93,395 Retained profit 2024: € 93,395 ▲ 4% vs 2023 (€ 90,153) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 29,000 Dividend 2023: € 29,000 Unchanged (€ 0) Unchanged	€ 25,600 Dividend 2024: € 25,600 ▼ 12% vs 2023 (€ 29,000) Unchanged	▼ 12%
Balance sheet total	€ 130,523 Balance sheet total 2021: € 130,523 First fiscal year in the series	€ 144,612 Balance sheet total 2022: € 144,612 ▲ 11% vs 2021 (€ 130,523) Unchanged	€ 153,072 Balance sheet total 2023: € 153,072 ▲ 6% vs 2022 (€ 144,612) Unchanged	€ 117,310 Balance sheet total 2024: € 117,310 ▼ 23% vs 2023 (€ 153,072) Unchanged	▼ 23%

Key figures of Docteur Christophe CHANTRAIN, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Docteur Christophe CHANTRAIN?

What happened at Docteur Christophe CHANTRAIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2025 New annual accounts for financial year 2024: profit of € 28,843 (▲ 266% vs 2023). filed late Source: NBB ↗
Dec 10, 2013 New establishment in Dalhem. KBO
Dec 10, 2013 Start of the company according to the CBE. KBO

In short

From € 32,556 profit in 2021 to € 28,843 profit in 2024.

Paid € 39,390 in corporate taxes since 2021.

Best year ever: 2021, with € 32,556 profit.

Paid out € 54,600 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur Christophe CHANTRAIN? We notify you, reason included.

Follow Docteur Christophe CHANTRAIN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Nathalie MATHURIN Christophe CHANTRAIN

Docteur Christophe CHANTRAIN

Belgian Society of Pediatric Heamatology-Oncology

Behind Docteur Christophe CHANTRAIN are Nathalie MATHURIN and Christophe CHANTRAIN. Christophe CHANTRAIN is also behind Belgian Society of Pediatric Heamatology-Oncology.

See the full network in the app

Directors

According to the 2024 annual accounts

Nathalie MATHURIN

Director

Christophe CHANTRAIN

Director

Also active at: Belgian Society of Pediatric Heamatology-Oncology

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin du Bois du Roi(WAR) 43

4608 Dalhem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0542.859.114
VAT number: BE 0542.859.114
Registered office: Chemin du Bois du Roi(WAR) 43, 4608 Dalhem
Names & denominations: Docteur Christophe CHANTRAIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 December 2013
Peppol: Active · Active since 13 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗